β¨ Medicine Notices
26 AUGUST NEW ZEALAND GAZETTE 2427
Active Ingredient(s): Ciprofloxacin hydrochloride 116.44 mg/mL equivalent to 100 mg/mL ciprofloxacin.
Dosage Form: Oral suspension.
NZ Sponsor: Bayer New Zealand Limited Health Care Division.
Manufacturer(s): Bayer SpA, Garbagnate, Milanese, Italy.
Product: Ciproxin.
Active Ingredient(s): Ciprofloxacin hydrochloride 58.22 mg/mL equivalent to 50 mg/mL ciprofloxacin.
Dosage Form: Oral suspension.
NZ Sponsor: Bayer New Zealand Limited Health Care Division.
Manufacturer(s): Bayer SpA, Garbagnate, Milanese, Italy.
Product: Ciproxin.
Active Ingredient(s): Ciprofloxacin hydrochloride 100 mg.
Dosage Form: Tablet.
NZ Sponsor: Bayer New Zealand Limited Health Care Division.
Manufacturer(s): Bayer AG, Leverkusen, Germany.
Product: Ciproxin.
Active Ingredient(s): Ciprofloxacin hydrochloride 250 mg.
Dosage Form: Tablet.
NZ Sponsor: Bayer New Zealand Limited Health Care Division.
Manufacturer(s): Bayer AG, Leverkusen, Germany.
Product: Ciproxin.
Active Ingredient(s): Ciprofloxacin hydrochloride 500 mg.
Dosage Form: Tablet.
NZ Sponsor: Bayer New Zealand Limited Health Care Division.
Manufacturer(s): Bayer AG, Leverkusen, Germany.
Product: Ciproxin.
Active Ingredient(s): Ciprofloxacin hydrochloride 750 mg.
Dosage Form: Tablet.
NZ Sponsor: Bayer New Zealand Limited Health Care Division.
Manufacturer(s): Bayer AG, Leverkusen, Germany.
Product: Esmeron.
Active Ingredient(s): Rocuronium bromide 10 mg/mL.
Dosage Form: Solution for injection.
NZ Sponsor: Pharmaco (NZ) Limited.
Manufacturer(s): Organon International BV, Oss, The Netherlands.
Organon Laboratories Limited, Newhouse, Motherwell, Lanarkshire, Scotland.
Organon SA, Usine Saint-Charles, Eragny-sur-Epte, Serifontaine, France.
Product: Kliovance.
Active Ingredient(s): Norethisterone acetate 0.5 mg.
Oestradiol hemihydrate 1.03 mg equivalent to 1 mg oestradiol.
Dosage Form: Film coated tablet.
NZ Sponsor: Novo Nordisk Pharmaceuticals Limited.
Manufacturer(s): Novo Nordisk A/S, Maaloev, Denmark.
Product: Valtrex.
Active Ingredient(s): Valaciclovir hydrochloride 1,112 mg equivalent to 1,000 mg valaciclovir.
Dosage Form: Film coated tablet.
NZ Sponsor: Glaxo Wellcome New Zealand Limited.
Manufacturer(s): Glaxo Wellcome Operations, Temple Hill, Dartford, Kent, United Kingdom.
Product: Valtrex.
Active Ingredient(s): Valaciclovir hydrochloride 278 mg equivalent to 250 mg valaciclovir.
Dosage Form: Film coated tablet.
NZ Sponsor: Glaxo Wellcome New Zealand Limited.
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1999, No 101
NZLII —
NZ Gazette 1999, No 101
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social WelfareMedicines Act 1981, Changed Medicine, Distribution Consent, Oral suspension, Tablet, Solution for injection